Attached files
| file | filename |
|---|---|
| 10-K - FORM 10-K - HARROW HEALTH, INC. | a55620e10vk.htm |
| EX-32 - EX-32 - HARROW HEALTH, INC. | a55620exv32.htm |
| EX-31.1 - EX-31.1 - HARROW HEALTH, INC. | a55620exv31w1.htm |
| EX-10.21 - EX-10.21 - HARROW HEALTH, INC. | a55620exv10w21.htm |
EXHIBIT 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the incorporation by reference in Registration Statement No. 333-159159 on Form S-8
of our report dated March 31, 2010, relating to the consolidated financial statements of Transdel
Pharmaceuticals, Inc. and subsidiaries (the “Company”) (which report expresses an unqualified
opinion and includes an explanatory paragraph relating to the substantial doubt about the Company’s
ability to continue as a going concern), appearing in this Annual Report on Form 10-K of Transdel
Pharmaceuticals, Inc. for the year ended December 31, 2009.
| /s/ KMJ Corbin & Company LLP | ||||
| Costa Mesa, California | ||||
| March 31, 2010 | ||||